Amortal

In 2019, a medical company known as Coil Industries begins human trials of the controversial Amortal program. Aimed to have their cells replaced by self-replicating nanites, the two candidates, Jordan and Cass experience how becoming next stage of human evolution will affect them and others.

Statut

Sorti

Sortie

31/12/2022

Langue originale

Anglais